Disc Medicine Reports Second Quarter 2025 Financial Results and Provides Business Update
Company on track to submit NDA for bitopertin in erythropoietic protoporphyria (EPP) under accelerated approval pathway in October 2025, supported...
Pharmaceutical
Soligenix Inc. (NASDAQ: SNGX) Proprietary Platform Aims to Meet Growing Need for Effective CTCL Therapy
NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Soligenix Inc. (NASDAQ: SNGX) today announces its placement in...
Quoin Pharmaceuticals Announces Second Quarter 2025 Financial Results and Corporate Update
- Positive 6 Month Clinical Data Reported for Ongoing Pediatric Netherton Syndrome Study - FDA Clears Second Pivotal Study of...
Cellectar Biosciences to Report Second Quarter Financial Results and Host a Conference Call on Thursday, August 14, 2025
FLORHAM PARK, N.J., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused...
Ascentage Pharma to Report 2025 Six Month Interim Results and Provide Corporate Update on August 20, 2025
ROCKVILLE, Md. and SUZHOU, China, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage...
Daré Bioscience to Host Second Quarter 2025 Financial Results and Company Update Conference Call and Webcast on August 14, 2025
SAN DIEGO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a biopharmaceutical company with a sole focus of closing...
vTv Therapeutics Announces First Study Participant Randomized in CATT1 Phase 3 Trial of Cadisegliatin in Type 1 Diabetes
Topline results from CATT1 Phase 3 trial expected in second half of 2026HIGH POINT, N.C., Aug. 07, 2025 (GLOBE NEWSWIRE)...
RAPT Therapeutics Reports Second Quarter 2025 Financial Results
SOUTH SAN FRANCISCO, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT) (“RAPT” or the “Company”), a...
Barinthus Bio Reports Second Quarter 2025 Financial Results and Updates on Corporate Developments
The final cohort of the single ascending dose (SAD) part of the Phase 1 AVALON trial initiated, with the SAD...
Nualtis Announces Strategic Partnership with OrthoNu for Innovative Orthodontic Care Products
MONTREAL, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Nualtis (formerly IntelGenx Corp.), a leader in oral film drug delivery technologies, today...
MBX Biosciences Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights
Topline results for the Phase 2 Avail™ trial of canvuparatide in hypoparathyroidism on track for Q3 2025 Imapextide (MBX 1416)...
TRACEABILITY, QUALITY, SAFETY: OVER A DECADE OF ANTARES VISION GROUP’S CONTRIBUTION TO THE AFRICAN PHARMACEUTICAL SECTOR
The Group's advanced technologies and made in Italy quality ensure compliance to global standards, supply chain integrity and patient safety...
Massachusetts Cannabis Contamination Crisis Exposes Federal Negligence While DEA Targets Science, Not Safety
Where Is the DEA? The Real Threat Isn't Research-It's Rotten Weed."This is the height of hypocrisy," said Duane Boise, CEO...
Rx-360’s New SCAR Guide Streamlines Supplier Corrective Actions
Download the SCAR Guide + Blank Form for Free at Rx-360.org PHILADELPHIA, Aug. 6, 2025 /PRNewswire/ -- Rx-360 has released...
Viemed Healthcare Announces Second Quarter 2025 Financial Results
LAFAYETTE, LA / ACCESS Newswire / August 6, 2025 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), an in-home...
Zomedica Announces Second Quarter 2025 Financial Results: Revenue up 14% to $7 Million with 67% Gross Margins and $59 Million in Liquidity to Support Growth
Zomedica posts record year-over-year revenue for 18th straight quarter! ANN ARBOR, MI / ACCESS Newswire / August 6, 2025 /...
Deep Rx Inc. Appoints Dr. Stanley Marks, Chairman of UPMC Hillman Cancer Center, to Board of Directors to Advance AI-Driven Precision Oncology
PITTSBURGH, PA / ACCESS Newswire / August 6, 2025 / Deep Rx Inc., a predictive analytics company advancing AI-driven solutions...
Avel eCare Hosts National Emergency Airway Course to Sharpen Life-Saving Intubation Skills
90+ medical professionals gather in Sioux Falls for hands-on training, real-time telemedicine support, and continuing education through AVELearn SIOUX FALLS,...
Colorado Eye Consultants Owner Dr. Robert Fish Honored as 5280 Magazine Top Doctor for 2025
LITTLETON, CO / ACCESS Newswire / August 6, 2025 / Colorado Eye Consultants announces that owner Dr. Robert Fish has...
Colorado Eye Consultants Founding Owner Dr. Lance Forstot Named 5280 Magazine Top Doctor for 2025
LITTLETON, COLORADO / ACCESS Newswire / August 6, 2025 / Colorado Eye Consultants is proud to announce that founding owner...